• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy.

作者信息

MELICOW M M

出版信息

J Urol. 1952 Jul;68(1):261-79. doi: 10.1016/S0022-5347(17)68193-X.

DOI:10.1016/S0022-5347(17)68193-X
PMID:14939458
Abstract
摘要

相似文献

1
Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy.全膀胱切除术中大体肿瘤之间膀胱尿路上皮的组织学研究。
J Urol. 1952 Jul;68(1):261-79. doi: 10.1016/S0022-5347(17)68193-X.
2
Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.接受根治性膀胱切除术治疗膀胱移行细胞癌的女性患者残余尿路上皮肿瘤复发：单中心长期结果
J Urol. 2006 Apr;175(4):1268-71; discussion 1271. doi: 10.1016/S0022-5347(05)00643-9.
3
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.根治性膀胱切除术后残余尿路上皮转归的系统评价
Eur Urol. 2017 Apr;71(4):545-557. doi: 10.1016/j.eururo.2016.09.035. Epub 2016 Oct 6.
4
Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.膀胱尿路上皮癌中，膀胱切除标本正常尿路上皮丝氨酸苏氨酸激酶 15 扩增不是预后因素。
Pathol Res Pract. 2011 Mar 15;207(3):161-3. doi: 10.1016/j.prp.2010.12.006. Epub 2011 Jan 17.
5
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.膀胱癌患者组织学良性尿路上皮中低水平的STK15扩增对膀胱切除术后患者的预后有不良预测作用。
Int J Oncol. 2007 Oct;31(4):793-802.
6
Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.局部肌层浸润性膀胱癌行三联疗法与根治性膀胱切除术的疗效比较。
Eur Urol. 2017 Oct;72(4):483-487. doi: 10.1016/j.eururo.2017.03.038. Epub 2017 Apr 12.
7
Facing the Fate of the Remnant Urothelium After Radical Cystectomy: There Is Room for Improvement.
Eur Urol. 2017 Apr;71(4):558-559. doi: 10.1016/j.eururo.2016.11.016. Epub 2016 Nov 22.
8
Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.膀胱尿路上皮移行细胞癌中，肌肉浸润诊断与根治性膀胱切除术之间的时间间隔对预后的意义。
Scand J Urol Nephrol. 2004;38(3):231-5. doi: 10.1080/00365590410029141.
9
Bladder Tumor Subtype Commitment Occurs in Carcinoma Driven by Key Signaling Pathways Including ECM Remodeling.膀胱癌亚型的形成与关键信号通路有关，包括细胞外基质重塑，这些通路驱动了癌的发生。
Cancer Res. 2021 Mar 15;81(6):1552-1566. doi: 10.1158/0008-5472.CAN-20-2336. Epub 2021 Jan 20.
10
Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder.SIRT6在膀胱肌层浸润性尿路上皮癌中的表达及功能
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6504-13. eCollection 2014.

引用本文的文献

1
Carcinoma in situ within the bladder trigone with an isolated metastasis to the prostate without involvement of prostatic urethra: a unique case report.膀胱三角区原位癌伴孤立性前列腺转移而不累及前列腺尿道：独特病例报告。
BMC Urol. 2024 Jun 15;24(1):127. doi: 10.1186/s12894-024-01516-6.
2
Orthotopic neobladder after cystectomy for bladder cancer.膀胱癌膀胱切除术后的原位新膀胱。
Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(7):255-265. doi: 10.2183/pjab.96.019.
3
Bacillus Calmette-Guérin (BCG) Treatment Failures in Non-Muscle Invasive Bladder Cancer: What Truly Constitutes Unresponsive Disease.
卡介苗（BCG）治疗非肌层浸润性膀胱癌失败：真正构成无反应疾病的因素是什么。
Bladder Cancer. 2015 Oct 26;1(2):105-116. doi: 10.3233/BLC-150015.
4
Different subtypes of carcinoma in situ of the bladder do not have a different prognosis.不同亚型的膀胱原位癌并无不同的预后。
Virchows Arch. 2013 Mar;462(3):343-8. doi: 10.1007/s00428-013-1378-4. Epub 2013 Feb 10.
5
Clinical outcome of primary versus secondary bladder carcinoma in situ.原发性与继发性膀胱癌原位的临床转归。
J Urol. 2010 Aug;184(2):464-9. doi: 10.1016/j.juro.2010.03.134. Epub 2010 Jun 17.
6
The experimental implantation of tumour cells in the urinary tract.肿瘤细胞在尿路中的实验性植入。
Br J Cancer. 1958 Dec;12(4):622-30. doi: 10.1038/bjc.1958.70.
7
The cytological diagnosis of bladder tumours amongst dyestuff workers.染料工人膀胱肿瘤的细胞学诊断
Br J Ind Med. 1956 Oct;13(4):270-6. doi: 10.1136/oem.13.4.270.
8
Medical management of patients with refractory carcinoma in situ of the bladder.膀胱原位癌难治性患者的医学管理。
Drugs Aging. 2001;18(5):335-44. doi: 10.2165/00002512-200118050-00004.
9
Carcinoma in situ and treatment options.原位癌及治疗选择。
Int Urol Nephrol. 1996;28(1):33-42. doi: 10.1007/BF02550135.
10
Superficial bladder carcinoma. Factors affecting the natural history.
World J Urol. 1993;11(3):142-7. doi: 10.1007/BF00211408.